Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Cerilliant
Express Scripts
Cipla
McKesson
Chubb
Citi
Novartis
Colorcon
Boehringer Ingelheim

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076817

« Back to Dashboard
NDA 076817 describes SULFAMETHOXAZOLE AND TRIMETHOPRIM, which is a drug marketed by Interpharm, Watson Labs, Teva Pharms Usa, Usl Pharma, Mutual Pharm, Martec Usa Llc, Ani Pharms Inc, Teva, Pliva, Sun Pharm Inds, Vista Pharms, Abraxis Pharm, Aurobindo Pharma, West-ward Pharms Int, Glenmark Generics, Heather, Hi Tech Pharma, Chartwell Molecules, Roxane, Bedford, Vintage, Sandoz, Hospira, Amneal Pharms Ny, Able, and Teva Pharms, and is included in forty-four NDAs. It is available from sixty-one suppliers. Additional details are available on the SULFAMETHOXAZOLE AND TRIMETHOPRIM profile page.

The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.

Summary for NDA: 076817

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 076817

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
TABLET;ORAL 076817 ANDA Blenheim Pharmacal, Inc. 10544-926 10544-926-20 20 TABLET in 1 BOTTLE (10544-926-20)
SULFAMETHOXAZOLE AND TRIMETHOPRIM
sulfamethoxazole; trimethoprim
TABLET;ORAL 076817 ANDA Northwind Pharmaceuticals 51655-111 51655-111-20 20 TABLET in 1 BOTTLE, DISPENSING (51655-111-20)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG;80MG
Approval Date:Oct 7, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength800MG;160MG
Approval Date:Oct 7, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Covington
Accenture
Cipla
McKinsey
Fish and Richardson
Chubb
Citi
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot